Agenda

CANCER RESEARCH DAY AGENDA – MAY 2, 2024

IUPUI Campus Center, 420 University Blvd.

8 - 8:30 AM

Breakfast (Theater room, lower level)

8:30 - 9 AM

 

 

Targeting tumors and the TME via CD4 CAR T cells 

Huda Salman, M.D., Ph.D.
Director, Brown Center for Immunotherapy
Don Brown Professor of Immunotherapy
IU School of Medicine 

(Theater room, lower level)

9 - 9:30 AM 

 

“Pediatric Precision Genomics: From Bedside to Bench and Back 

Michael Ferguson, M.D.

Associate Professor of Clinical Pediatrics
Medical Director, Pediatric Cancer Precision Genomics Program
IU School of Medicine 

(Theater room, lower level)

9:30 - 10 AM

“Development of PIM2 modulators for Multiple Myeloma; case study using the IUSCCC Cancer Drug Discovery and Development Accelerator (CD3A

Chafiq Hamdouchi, Ph.D.
Senior Research Professor of Pathology & Laboratory Medicine
IU School of Medicine

(Theater room, lower level) 

10 - 10:15 AM

Community Outreach & Engagement

Katharine Head, Ph.D.
Associate Professor of Communication Studies
Director, PhD Graduate Program in Health Communications
IU School of Liberal Arts

(Theater room, lower level)

10:15 - 11 AM

Selected Oral Presentations (Post-Docs/Medical Fellows)
(10 min & 5 min Q&A) 

(Theater room, lower level)

11 AM - 2 PM

Cancer Research Day Poster Session

(Multipurpose Room 450 A, B, C / Lunch provided to attendees during poster session) *Split in to two sessions*

First Session - 11 a.m. to 12:30 p.m.
Second Session - 12:30 p.m. to 2:00 p.m.

2 - 3 PM

Selected Oral Presentations (Graduate students)
(10 min & 5 min Q&A) 

(Theater room, lower level)

3 - 4 PM

 

 

Keynote Address: 

Translational Research to Transformative Therapies"

Varsha Gandhi, Ph.D.
Waun Ki Hong Distinguished Chair in Translational Research
The University of Texas MD Anderson Cancer Center 

(Theater room, lower level)

4 - 4:30 PM

Awards Ceremony and Closing Remarks
(Theater room, lower level)

4:30 - 5:30 PM

Closing Reception. Drinks and hors d’oeuvres provided.
(Lower level lounge area located outside Theatre room)

Selected for Oral Presentations

Post-Doc/Medical Fellow/ Resident

10:15 - 10:30 AM - Pamela Mendoza-Munoz - IMPACT OF OPTIMIZED KU-DNA BINDING INHIBITORS ON THE CELLULAR AND IN VIVO DNA DAMAGE RESPONSE TO DSB GENERATING THERAPIES 

10:30 – 10:45 AM - Subramanyam Dasari - TARGETING THE METASTATIC NICHE MEDIATED ACTIVATION OF METASTASIS INITIATING CELLS IN HIGH GRADE SEROUS OVARIAN CANCER 

10:45 – 11:00 AM – Rebeccas Hassoun - UTILITY OF CIRCULATING TUMOR DNA (CTDNA) AS A PREDICTIVE BIOMARKER FOR DISEASE MONITORING IN PATIENTS WITH NON-SEMINOMATOUS GERM-CELL TUMOR (NSGCT) 


Graduate Students

2:00 – 2:15 PM – Avery Runnebohm - IB-DNQ AND RUCAPARIB DUAL TREATMENT ALTERS CELL CYCLE REGULATION AND DNA REPAIR IN TRIPLE NEGATIVE BREAST CANCER CELLS 

2:15 – 2:30 PM – Madhura Shirish Shukla - EFFECTS OF PROCR+/ ZEB1+/ PDGFRα+ FIBROBLASTS ON BREAST TUMOR MICROENVIRONMENT 

2:30 – 2:45 PM – Yanchi Zhou - STABILIZATION OF CHECKPOINT KINASE 1 BY THE LNCRNA HOTAIR PROMOTES PARP INHIBITOR RESISTANCE IN HOMOLOGOUS RECOMBINATION PROFICIENT HIGH GRADE SEROUS OVARIAN CANCER 

2:45 – 3:00 PM – Emily White - EVALUATING THE ROLE OF T CELLS IN NF1-PERIPHERAL NERVE SHEATH TUMOR (PNST) PROGRESSION

#ResearchCuresCancer

Support Our Research